ArticleFrontiers in medicine2026
Effects of continuous care based on a mobile health platform on self-management behaviors and quality of life in patients with acute leukemia.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To evaluate the effects of continuous care delivered via a mobile health (mHealth) platform on self-management behaviors, quality of life (QoL), medication adherence, psychological distress, daytime sleepiness, cancer-related fatigue (CRF), complications, and rehospitalization in patients with acute leukemia (AL). Methods: A total of 108 AL patients discharged between January 2024 and January 2025 were randomly assigned to an observation group ( Results: Significant group × time interactions were observed for all continuous variables (all Conclusion: Continuous care based on an mHealth platform significantly improves self-management, QoL, medication adherence, psychological outcomes, daytime sleepiness, and fatigue at 3 and 6 months, and reduces complications and rehospitalizations in this single-center cohort of AL patients. These findings require multicenter validation in more diverse populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.